Evotec
Alfiia Latfullina is a highly skilled research professional with extensive experience in the field of cardiovascular science. Currently serving as a Senior Research Assistant at Evotec since April 2019, Alfiia previously held positions as a Research Assistant and Master Thesis Student at Georg-August-Universität Göttingen, where involvement included significant research under the guidance of leading professors. Early career experiences include roles as a Practicum Student at Georg-August-Universität Göttingen, and as an Intern Student at the University Giessen, with a focus on physiological research. Alfiia obtained a Master's degree in Cardiovascular Science from The University of Göttingen and a Bachelor's degree in Human and Animal Physiology from Kazan State University.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.